Customers in research and diagnostics labs tell us that scaling operations can often feel out of reach—particulary for smaller institutions or those with limited technical expertise. The VeyaTM platform, Tecan’s latest innovation in lab automation, is breaking down these barriers and opening up new opportunities for labs of all sizes.
Veya delivers a tailored user experience with predefined workflows that simplify even the most complex processes. By automating repetitive tasks and streamlining operations, Veya allows labs to focus on what matters most: delivering high-impact research and clinical results. One key advantage of Veya is its accessibility. Unlike traditional systems that require specialized training, Veya’s intuitive interface ensures that labs with varying levels of technical expertise can confidently adopt automation. This accessibility is particularly valuable for labs in diagnostics, where staff shortages and growing workloads create significant challenges.
Remote monitoring and the OneViewTM display further enhance productivity by providing live, intelligent analytics into operational workflows. These tools minimize downtime and allow lab personnel to focus on higher-value tasks while reducing human error. Consider a small diagnostics lab facing increasing demands with limited skilled personnel: implementing Veya enables the lab to scale its throughput, streamline workflows and meet rising demands efficiently. Predefined workflows speed up setup times and eliminate the need for scripting expertise, reducing the risk of human error. This allows the lab to deliver results faster while maintaining compliance and quality. Early adopters are already leveraging Veya’s potential in advanced multiomics research. For instance, Dr. Bogdan
Budnik, a leading researcher and chair at a prominent proteomics organization, recently shared his enthusiasm about receiving the very first Veya instrument:
"We just received the very first Veya instrument from Tecan Switzerland, and I couldn't be happier! A huge thank you to the incredible team for setting it up in record time. Our plan is to utilize this cool new platform for a comprehensive multimodal workflow based on single cells. I'm eagerly anticipating the data we'll gather, especially with our first applications in proteomics." Dr. Budnik’s team plans to use Veya for comprehensive single-cell workflows in proteomics, metabolomics and lipidomics. Their work demonstrates Veya’s scalability and versatility for cutting-edge research, highlighting how the system can support complex, high-resolution studies that have previously been challenging for smaller labs.
By simplifying workflows, increasing inclusivity, accessibility and enabling scalability, Veya reinforces Tecan’s role in building an efficient, accessible healthcare ecosystem. Whether in diagnostics, research or clinical applications. Veya ensures that labs of all sizes can scale their operations without added complexity.